Lineage Cell Therapeutics (LCTX) Total Debt Growth (1y) (2015 - 2017)
Lineage Cell Therapeutics (LCTX) Total Debt Growth (1y) (2015 - 2017) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 5.94% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -85.00% |
| Sep 30, 2017 | -74.57% |
| Jun 30, 2017 | -45.09% |
| Mar 31, 2017 | -56.82% |
| Dec 31, 2016 | -51.22% |
| Sep 30, 2016 | -35.45% |
| Jun 30, 2016 | 5,666.67% |
| Mar 31, 2016 | 1,171.16% |
| Dec 31, 2015 | 693.55% |
| Sep 30, 2015 | 496.05% |
| Jun 30, 2015 | -94.78% |